Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines is a research paper published in Cancers (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institute of Health
Grant: R01 CA240983
National Cancer Institute Cancer Center
Grant: P30-CA091842
National Cancer Institute
Grant: T32 CA009621
NIH HHS
Grant: 1R01CA240983-25
NIH HHS
Grant: 1T32CA009621-26
Foundation for Barnes-Jewish Hospital
Grant: B5138-80
NIH HHS
Grant: 1P30CA091842-27
FWCI
0.71
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords